Dear colleagues in Latin America, I am greatly pleased to inform that the 8th edition of the Interventional Trainees Course, “José Gabay,” organized by ProEducar-SOLACI along with the Argentine College of Interventional Cardiology (CACI), took place on August 1st. The success of this course, year after year, is based on its acceptance by the...
Early Invasive Strategy Benefits High-Risk Patients
Early angiography is not associated with a reduction in mortality compared with a more delayed invasive strategy in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS). However, a new meta-analysis published by The Lancet supports the idea that certain high-risk patients would benefit from it. Patients with elevated cardiac biomarkers, a high GRACE score, diabetes, or advanced...
Striking Finding on Diabetes and Bypass Graft Patency
The higher rate of restenosis in the diabetic population is historic and has been reproduced in all studies and with all kinds of stents, but it was only after the FREEDOM trial when we found out about the higher infarction rate with PCI compared to surgery. This is why 50% of patients undergoing CABG are diabetic. Apart from the above...
“José Gabay” Course: Interview to Leandro Lasave
After the successful 8th edition of the ProEducar “José Gabay” Course (which took place on August 1st, 2017, at the Hilton Buenos Aires Hotel), it is time to assess its outcomes. In this case, Dr. Leandro Lasave, the Director of the José Gabay Course, analyzed the results of the aforementioned course and SOLACI’s educational work in...
Positive Outcomes of CoreValve Evolut in Large Population
The Evolut R, as well as its predecessor the CoreValve, is a self-expandable valve, supra-annular, made of porcine pericardium in a nitinol frame. Amongst its improvements, it has a better profile and the option to resheath. This makes it fully repositionable and even recapturable. We only needed to confirm these technical advantages would translate into clinical...
Post TAVR Dialysis: a Severe Complication Less and Less Frequent
The prevalence of pre-procedural kidney failure in patients undergoing transcatheter aortic valve replacement (TAVR) can be as high as 50 – 60% (stage 3 kidney failure or worse); it has been strongly associated with acute kidney deterioration and, ultimately, an increase of post TAVR mortality. A recent meta-analyzis of several small studies carried out in a single...
2017 Colombia Sessions
34th SOLACI Regional Sessions – 11° Andrean Region. October 5th and 6th, 2017.Bogotá, Colombia. The XXXIV SOLACI Regional Sessions were held on October 05 and 06 in the city of Bogotá, Colombia. See the best images and news of the Colombia Sessions 2017.
Colombia Sessions: Contest for Young Interventionists
Sponsored by Abbott Vascular LATAM 34th SOLACI Regional Sessions – 11° Andrean Region. October 5th and 6th, 2017. Bogotá, Colombia. Case Submission: “Fostering Hemodynamics among Young Cardiologists”. It is with great pleasure that we hereby invite all young Latin American cardiologists specializing in hemodynamics to submit relevant clinical cases to the next SOLACI Sessions, Bogotá, Colombia, to be...
Nicaragua Sessions: Contest for Young Interventionists
Sponsored by Abbott Vascular LATAM 33rd SOLACI Regional Sessions – 12° Central America and the Caribbean Regional Meeting September 29th and 30th, 2017. Managua, Nicaragua. Case Submission: “Fostering Hemodynamics among Young Cardiologists”. It is with great pleasure that we hereby invite all young Latin American cardiologists specializing in hemodynamics to submit relevant clinical cases to the...
Are Bioresorbable-Polymer Stents More Thrombogenic than Durable-Polymer Second-Generation Stents?
Courtesy of Dr. Cristian Jesús Rodríguez. Most stents currently used in percutaneous coronary intervention (PCI) are durable-polymer second-generation drug-eluting stents (DP-DES, with everolimus or zotarolimus). However, it has been argued that the persistence of such a polymer after complete drug elution is one of the main factors for a dangerous complication: stent thrombosis (ST). After...